This issue of Clinics in Laboratory Medicine, edited by Drs. Anthony Odibo and David A. Krantz, covers issues surrounding Prenatal Screening and Diagnosis. Topics examined in this issue include, but are not limited to: Strategies for Implementing cfDNA Testing; Genetic Counselling for Patients Considering Screening and Diagnosis of Chromosomal Abnormalities; Microdeletions/Duplications; Sex Chromosome Abnormalities; First-, Second- and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction; Biophysicial/Biochemical Screening for the Risk of Preterm Labor; Preimplantation Genetic Testing; Toxoplasmosis, Parvovirus and Cytomegalovirus in Pregnancy; and Sleep Apnea and Adverse pregnancy Outcomes.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 6 7. Preface: Prenatal Screening: The Birth of a New Era - p. 7 8. Cell-free DNA - p. 8 9. Strategies for Implementing Cell-Free DNA Testing - p. 16 10. Genetic Counseling for Patients Considering Screening and Diagnosis for Chromosomal Abnormalities - p. 24 11. Cost-Effectiveness of Old and New Technologies for Aneuploidy Screening - p. 30 12. Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result - p. 36 13. Chromosomal Microarrays for the Prenatal Detection of Microdeletions and Microduplications - p. 42 14. Genetic Carrier Screening in the Twenty-first Century - p. 49 15. Screening and Testing in Multiples - p. 57 16. Inverted Pyramid of Care - p. 66 17. Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction - p. 74 18. First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction - p. 80 19. Maternal Serum Analytes as Predictors of Fetal Growth Restriction with Different Degrees of Placental Vascular Dysfunction - p. 89 20. Biophysical and Biochemical Screening for the Risk of Preterm Labor - p. 96 21. The Past, Present, and Future of Preimplantation Genetic Testing - p. 102 22. Screening for Open Neural Tube Defects - p. 112 23. Toxoplasmosis, Parvovirus, and Cytomegalovirus in Pregnancy - p. 116 24. Prenatal Screening for Thrombophilias - p. 124 25. Sleep Disordered Breathing and Adverse Pregnancy Outcomes - p. 132
No hay muestra disponible
No hay ficha técnica disponible
This issue of Clinics in Laboratory Medicine, edited by Drs. Anthony Odibo and David A. Krantz, covers issues surrounding Prenatal Screening and Diagnosis. Topics examined in this issue include, but are not limited to: Strategies for Implementing cfDNA Testing; Genetic Counselling for Patients Considering Screening and Diagnosis of Chromosomal Abnormalities; Microdeletions/Duplications; Sex Chromosome Abnormalities; First-, Second- and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction; Biophysicial/Biochemical Screening for the Risk of Preterm Labor; Preimplantation Genetic Testing; Toxoplasmosis, Parvovirus and Cytomegalovirus in Pregnancy; and Sleep Apnea and Adverse pregnancy Outcomes.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. Contributors - p. 5 6. Forthcoming Issues - p. 6 7. Preface: Prenatal Screening: The Birth of a New Era - p. 7 8. Cell-free DNA - p. 8 9. Strategies for Implementing Cell-Free DNA Testing - p. 16 10. Genetic Counseling for Patients Considering Screening and Diagnosis for Chromosomal Abnormalities - p. 24 11. Cost-Effectiveness of Old and New Technologies for Aneuploidy Screening - p. 30 12. Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result - p. 36 13. Chromosomal Microarrays for the Prenatal Detection of Microdeletions and Microduplications - p. 42 14. Genetic Carrier Screening in the Twenty-first Century - p. 49 15. Screening and Testing in Multiples - p. 57 16. Inverted Pyramid of Care - p. 66 17. Aspirin for the Prevention of Preeclampsia and Intrauterine Growth Restriction - p. 74 18. First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction - p. 80 19. Maternal Serum Analytes as Predictors of Fetal Growth Restriction with Different Degrees of Placental Vascular Dysfunction - p. 89 20. Biophysical and Biochemical Screening for the Risk of Preterm Labor - p. 96 21. The Past, Present, and Future of Preimplantation Genetic Testing - p. 102 22. Screening for Open Neural Tube Defects - p. 112 23. Toxoplasmosis, Parvovirus, and Cytomegalovirus in Pregnancy - p. 116 24. Prenatal Screening for Thrombophilias - p. 124 25. Sleep Disordered Breathing and Adverse Pregnancy Outcomes - p. 132
No hay muestra disponible
No hay ficha técnica disponible
